Evidence map›Paper›PMID 37110238›Full record

ArticleMetabolites2023

Thymoquinone Antifungal Activity against

Noura Nouri, Shahla Roudbar Mohammadi, Justin Beardsley, Peyman Aslani, Fatemeh Ghaffarifar, Maryam Roudbary, Célia Fortuna Rodrigues

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Targeting Oral Pathogens withAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Emergence ofMini reviews in medicinal chemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Noura NouriDepartment of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115111, Iran.
Shahla Roudbar MohammadiDepartment of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115111, Iran.
Justin BeardsleySydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW 2145, Australia.ORCID 0000-0003-1978-1559
Peyman AslaniDepartment of Parasitology and Mycology, Faculty of Medicine, Aja University of Medical Sciences, Tehran 1411718541, Iran.
Fatemeh GhaffarifarDepartment of Parasitology and Entomology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115111, Iran.
Maryam RoudbaryDepartment of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran.
Célia Fortuna RodriguesTOXRUN-Toxicology Research Unit, Cooperativa de Ensino Superior Politécnico e Universitário-CESPU, 4585-116 Gandra PRD, Portugal.ORCID 0000-0001-8633-2230
Tarbiat Modares University · IRAja University of Medical Sciences · IRIran University of Medical Sciences · IRThe University of Sydney · AUUniversidade do Porto · PT

Funding

Tarbiat Modares University (TMU) IR.REC.1400.109.
6 · The paper itself

Abstract

The number of

Indexed as

antifungal susceptibilityCandida glabrataEPA6 and EPA7oral candidiasisthymoquinone

Identifiers

PMID37110238
PMCPMC10143056
OpenAlexW4366771637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.